J&J Wins First Tylenol Liver Damage Trial

By Sindhu Sundar (October 16, 2015, 8:00 PM EDT) -- Johnson & Johnson and its subsidiary McNeil Consumer Healthcare on Friday won the first trial over the alleged liver damage risks of McNeil's Extra Strength Tylenol when a New Jersey state jury found that it was not clear whether the woman claiming the painkiller was defectively designed had taken the Extra Strength version....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!